Status:

RECRUITING

Adapting the FACETS Program to Sickle Cell Disease

Lead Sponsor:

Versailles Hospital

Collaborating Sponsors:

University Hospital, Grenoble

University Grenoble Alps

Conditions:

Fatigue Symptom

Sickle Cell Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle c...

Eligibility Criteria

Inclusion Criteria:

  • Participant having freely given his oral agreement.
  • Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
  • Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.

Exclusion Criteria:

  • Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints.
  • Participants with another chronic pathology causing fatigue.
  • Participants in vaso-occlusive crisis (VOC) or hospitalization.
  • Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).

Key Trial Info

Start Date :

January 10 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 2 2026

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT06650813

Start Date

January 10 2025

End Date

May 2 2026

Last Update

August 19 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

CHU Grenoble Alpes

Grenoble, France, 38000

2

Hospital Versailles

Le Chesnay, France, 78150